Alfacell stock takes a hit on Onconase data
This is a discussion on Alfacell stock takes a hit on Onconase data within the Biotechnology News forum, part of the Industry News and Updates category; New Jersey-based Alfacell took a major hit this morning as it announced that its drug Onconase missed the primary ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-29-2008, 03:27 PM
|
|||
|
|||
Alfacell stock takes a hit on Onconase data
New Jersey-based Alfacell took a major hit this morning as it announced that its drug Onconase missed the primary endpoint in a Phase III study. The drug failed to improve survival rates of patients Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA takes action to stop the marketing of unapproved injectable drugs containing colc | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |